Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ajay Antony

Interventional Pain Medicine Gainesville, FL Medical Doctor

NPI 1770875700 CMS profile 954727

4500 Newberry Rd, Gainesville, FL 32607

Open in the dashboard

General payments

$1,056,236

1,464 records reported · program years 2019–2025

Research payments

$4,000

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$819,128 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Ajay Antony of Gainesville, FL is reported in the CMS Open Payments database as having received $1,056,236 across 1,464 general payments and $4,000 in research payments paid to them. Separately, studies naming them as principal investigator received $819,128 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $191,581 145
2024 General $128,517 165
2023 General $138,837 195
2022 General $131,743 191
2022 Research $4,000 2
2021 General $270,282 434
2020 General $111,385 200
2019 General $83,891 134

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ajay Antony
  • Interventional Pain Medicine median
  • Middle half of Interventional Pain Medicine
  • National median

In program year 2025, general payments to Ajay Antony were reported at $191,581. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.

Show as a table
Year Ajay Antony Interventional Pain Medicine median Middle half National median
2019 $83,891 $684 $216–$2,079 $163
2020 $111,385 $382 $122–$1,109 $114
2021 $270,282 $552 $167–$1,554 $132
2022 $131,743 $605 $187–$1,924 $149
2023 $138,837 $671 $195–$1,915 $160
2024 $128,517 $684 $206–$1,837 $164
2025 $191,581 $657 $184–$1,753 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $377,120 489 payments
  2. Abbott Laboratories $268,962 551 payments
  3. Saluda Medical Americas, Inc. $229,364 153 payments
  4. Vertos Medical, Inc. $66,118 92 payments
  5. Painteq LLC $47,814 52 payments
  6. IZI Medical Products, LLC $22,250 1 payment
  7. Stryker Corporation $18,521 18 payments
  8. Vertiflex, Inc. $8,407 13 payments
  9. Spinal Simplicity, LLC $5,713 8 payments
  10. Biotronik Inc. $4,125 4 payments
  11. Other $7,843 83 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $498,606 287 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $324,904 160 payments
  3. Travel and Lodging $91,024 280 payments
  4. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $41,300 34 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $37,410 32 payments
  6. Food and Beverage $34,257 644 payments
  7. Education $26,415 24 payments
  8. Honoraria $2,295 2 payments
  9. Entertainment $25 1 payment
Products named General payments · program years 2019–2025
  1. Evoke $167,943 95 payments
  2. Superion $102,111 91 payments
  3. Neuromodulation Dspsbls and Accs $100,118 109 payments
  4. mild Device Kit $65,658 87 payments
  5. Evoke SCS $61,282 57 payments
  6. PROCLAIM $57,080 112 payments
  7. PAINTEQ $47,814 52 payments
  8. WaveWriter Alpha Prime 16 $47,520 97 payments
  9. VERIFLEX $27,467 7 payments
  10. WAVEWRITER ALPHA $27,366 31 payments
  11. Other $273,507 660 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Painteq LLC $4,000 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

575

Median for Anesthesiology: 322

Drug cost

$12,667

Median for Anesthesiology: $8,738

Branded share of claims

53.6%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 167 $5,118
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 141 $3,840
Tramadol Hcl Generic 153 $2,609
Gabapentin Generic 57 $625
Cyclobenzaprine Hcl Generic 13 $187
Oxycodone Hcl Generic 14 $130
Methylprednisolone Generic 19 $118
Diazepam Generic 11 $40

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 77 billing codes

Paid by Medicare

$908,770

Of which drugs: $12,019

Medicare patients

1,041

Average age 76

Services billed

101,624

664 women, 377 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 40%
Diabetes 32%
Chronic kidney disease 29%
Depression 26%
Osteoporosis 25%
Atrial fibrillation 21%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 528 57,420 $5,834
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 770 38,747 $4,022
Injection, methylprednisolone acetate, 80 mg J1040 Office 174 199 $1,482
Injection, methylprednisolone acetate, 40 mg J1030 Office 50 56 $282
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 147 1,790 $160
Injection, cefazolin sodium, 500 mg J0690 Office 95 199 $124
Injection, fentanyl citrate, 0.1 mg J3010 Office 59 75 $55
Injection, midazolam hydrochloride, per 1 mg J2250 Office 35 78 $8

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
BOTOX
$24 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

1,466 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Pain Medicine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record